Chemo Side Affects Buffalo NY

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo.

Local Companies

Delaware Audiology Group, P.C.
(716) 886-6462
1083 Delaware Ave., Ste. 200
Buffalo, NY
Erie County Medical Center Corporation
(716) 898-3000
462 Grider St.
Buffalo, NY
Horizon Health Services
(716) 831-1800
3020 Bailey Ave., Second Fl.
Buffalo, NY
Dr. Robert J. Ciepiela
(716) 832-2762
2992 Bailey Ave.
Buffalo, NY
St. Francis of Buffalo
(716) 862-2500
34 Benwood Ave.
Buffalo, NY
Medical Care of WNY at Buffalo
(716) 883-0515
656 Elmwood Ave.
Buffalo, NY
WPC Math
(716) 882-6290
703 West Ferry St., C20
Buffalo, NY
Buffalo Hearing & Speech Center
(716) 885-8318
50 East North St.
Buffalo, NY
Buffalo General Hospital
(716) 859-5600
100 High St.
Buffalo, NY
Hauptman-Woodward Medical Research Institute, Inc.
(716) 898-8600
700 Ellicott St.
Buffalo, NY

A drug that better prevents the nausea and vomiting that commonly follows chemotherapy treatment for cancer may be on the horizon, Japanese researchers report.

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo, but is even better at preventing those side effects in the first five days.

In the phase III trial, about three-fourths of the people given either drug (both given in combination with dexamethasone) did not experience nausea and vomiting in the 24 hours immediately after receiving a chemotherapy regimen that included drugs most likely to cause vomiting -- cisplatin or a combination of anthracycline and cyclophosphamide, according to the study. However, nearly 57 percent of those on palonosetron avoided the ill effects in the first five days after treatment, compared with about 44 percent who had been given the standard granisetron regimen.

The study, which was released online and will appear in the February issue of The Lancet Oncology, reported similar safety records for the two drugs.

More information

The National Cancer Institute has more about chemotherapy side effects.

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Featured Local Company

Delaware Audiology Group, P.C.

(716) 886-6462
1083 Delaware Ave., Ste. 200
Buffalo, NY